Severe Hemophilia A Completed Phase 4 Trials for Antihemophilic factor, human recombinant (DB00025)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

IndicationStatusPhase
DBCOND0034640 (Severe Hemophilia A)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01085344Canadian Hemophilia Prophylaxis StudyTreatment